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Mitochondria are the primary energy-generating system in most eukaryotic cells. Addi-
tionally, they participate in intermediary metabolism, calcium signaling, and apoptosis. 
Given these well-established functions, it might be expected that mitochondrial dysfunc-
tion would give rise to a simple and predictable set of defects in all tissues. However, 
mitochondrial dysfunction has pleiotropic effects in multicellular organisms. Clearly, much 
about the basic biology of mitochondria remains to be understood. Here we discuss recent 
work that suggests that the dynamics (fusion and fission) of these organelles is important 
in development and disease.Mitochondria evolved from a symbiotic relationship 
between aerobic bacteria and primordial eukaryotic 
cells (Wallace, 2005). As the site of oxidative phospho-
rylation, these double-membrane organelles provide 
a highly efficient route for eukaryotic cells to generate 
ATP from energy-rich molecules. Electrons from oxida-
tive substrates are transferred to oxygen, via a series of 
redox reactions, to generate water. In the process, pro-
tons are pumped from the matrix across the mitochon-
drial inner membrane through respiratory complexes 
I, III, and IV. When protons return to the mitochondrial 
matrix down their electrochemical gradient, ATP is syn-
thesized via complex V (ATP synthase).
Although the vast majority of mitochondrial proteins 
(about 900) are encoded by the nuclear genome and 
imported into the mitochondria, mitochondria neverthe-
less maintain a genome that is essential for their respira-
tory function (Wallace, 2005). The 16 kilobase circular 
mitochondrial DNA (mtDNA) genome contains 37 genes. 
Thirteen of these genes encode protein subunits of respi-
ratory complexes I, III, IV, and V; only complex II is solely 
composed of proteins encoded by nuclear genes. The 
mtDNA genome also encodes 22 mitochondrial tRNAs 
and 2 rRNAs that are essential for translation of mtDNA 
transcripts. In spite of this simple genetic organization, 
key aspects of mtDNA mutations are poorly understood 
and, as argued here, will likely require a better under-
standing of the dynamic behavior (fusion and fission) of 
mitochondria.
Classic Mitochondrial Disorders
Classic mitochondrial disorders result from mutations in 
mtDNA or nuclear genes that disrupt mitochondrial res-
piratory function (Dimauro and Davidzon, 2005; DiMauro 
and Schon, 2003; Wallace, 2005). These diseases typi-
cally have brain and skeletal muscle manifestations, and therefore they are often referred to as mitochondrial 
encephalomyopathies. mtDNA mutations leading to 
such diseases were first discovered in 1988 (Holt et al., 
1988; Wallace et al., 1988), and now there are hundreds 
of point mutations, deletions, or rearrangements in 
mtDNA associated with disease (http://www.mitomap.
org). MERRF syndrome (myoclonic epilepsy associated 
with ragged-red fibers) is a well-studied mitochondrial 
encephalomyopathy and illustrates some of the salient 
features observed in mtDNA diseases. Patients with 
MERRF present with a mix of neurological and myo-
pathic symptoms, including myoclonic seizures, ataxia, 
and muscle weakness. In skeletal muscle biopsies, rag-
ged-red fibers are prominently detected (when stained 
with Gomori’s modified trichrome stain). Such ragged-
red fibers are a hallmark of many mitochondrial diseases 
and reflect the massive subsarcolemmal proliferation 
of mitochondria that often accompanies mitochondrial 
dysfunction in skeletal muscle. Lactic acidosis is also 
commonly observed in MERRF and many other mtDNA 
diseases and results from the poor ability of muscles 
lacking efficient respiration to use pyruvate produced by 
glycolysis. Excess pyruvate is converted to lactic acid, 
which enters the bloodstream.
Given that all mtDNA diseases lead to respiratory 
defects, it might be expected that their clinical pheno-
types would be similar. In fact, there is great clinical vari-
ability among these diseases, with many diseases char-
acterized by highly tissue-specific defects. For example, 
in MELAS syndrome (mitochondrial encephalomyopathy, 
lactic acidosis, and stroke-like episodes), the neurologi-
cal symptoms are quite different, marked by stroke-like 
episodes that can be severely debilitating and are often 
associated with infarctions within the brain. For both 
MERRF and MELAS, several distinct mtDNA mutations 
can give rise to the same clinical syndrome.Cell 125, June 30, 2006 ©2006 Elsevier Inc. 1241
Figure 1. Mitochondrial Fusion and Fission
Still frames from timelapse fluorescence movie 
(see Movie S1 for video) of YFP-labeled mito-
chondria in a living mouse embryonic fibroblast. 
Selected mitochondria are highlighted. In the 
first three frames, two pairs of mitochondria 
contact end-to-end and immediately fuse. In the 
last three frames, the lower fusion product un-
dergoes fission, and the daughter mitochondria 
move apart. Figure modified from the Journal of 
Cell Biology, 2003, vol. 160, p. 193 by copyright 
permission of the Rockefeller University Press 
(Chen et al., 2003).Diseases caused by mtDNA mutations have unique 
characteristics related to the biology of mitochondria 
(Dimauro and Davidzon, 2005; DiMauro and Schon, 
2003; Wallace, 2005). First, they are maternally inher-
ited, due to the transmission of mitochondria from 
the egg to the zygote. Paternal mitochondria from 
the sperm are selectively marked with ubiquitin and 
degraded. Second, the clinical symptoms progress 
with age. This feature is due to the accumulation of 
pathogenic mtDNA in specific tissues. In inherited 
mtDNA myopathies, the zygote inherits a mixture of 
pathogenic and wild-type mtDNA genomes, a state 
termed heteroplasmy. As heteroplasmic cells divide, 
the ratio of pathogenic to wild-type mtDNA genomes 
can vary among different tissues and among individ-
ual cells within tissues. This variation in mtDNA popu-
lations is probably due to the random distribution of 
mtDNA during cell division. As pathogenic mtDNA 
loads increase, there is a threshold beyond which cel-
lular dysfunction becomes apparent. In extreme cases, 
some tissues or cells may inherit a mitochondrial pop-
ulation containing only pathogenic mtDNA genomes, 
a state known as homoplasmy. Some mtDNA diseases 
are associated with homoplasmic mutations, and it is 
unclear why such diseases are also progressive.
Based on the tissues typically affected in mtDNA dis-
eases, it is generally thought that tissues such as brain, 
skeletal muscle, heart muscle, and endocrine glands are 
particularly dependent on respiratory function and have 
a lower bioenergetic threshold. Cells do not lose res-
piratory function until high loads of pathogenic mtDNA 
are present, ranging from 60% to 90% depending on 
the specific mutation (Hayashi et al., 1991; Nakada et 
al., 2001; Yoneda et al., 1994). This compensation likely 
depends at least partially on the ability of mitochondria 
to fuse and divide within cells (see Figure 1 and Movie S1 
available with this article online), thereby allowing com-
plementation of mtDNA gene products.
During most cell divisions, the mitochondrial popu-
lation within cells is evenly divided between the daugh-
ter cells. However, in special circumstances, such as 
during early oogenesis, there can be a drastic reduc-1242 Cell 125, June 30, 2006 ©2006 Elsevier Inc.tion in the total copy number of mtDNA that results in 
a genetic bottleneck (Shoubridge, 2000). Such bottle-
necks dramatically affect the ratio of mutant to wild-
type mtDNA and can result in rapid segregation of 
mutant mtDNA to some offspring. Because of the ran-
dom nature of mitochondrial segregation, mtDNA dis-
eases can have variable outcomes and an unpredict-
able course. An additional complication is that some 
mutant mtDNA may actually have a replicative advan-
tage over wild-type mtDNA. For example, transfer of 
mitochondria containing a mixture of wild-type and 
mutant mtDNA (conferring MELAS encephalopathy) 
to cells lacking mtDNA rapidly leads to homoplasmy 
or near-homoplasmy in most cell transformants. The 
mechanism for this preferential replication of mutant 
mtDNA is not clear, though selective stimulation of 
mtDNA replication in mitochondria with deficient res-
piration has been proposed (Yoneda et al., 1994).
In addition to the clinical diversity among different 
mtDNA diseases, it is perplexing that identical mtDNA 
mutations can give rise to distinct clinical disorders 
(DiMauro and Schon, 2003). In some cases, differ-
ences in mutational load may explain some of these 
features. In addition, the nuclear genome can clearly 
influence the outcome of mtDNA mutations. However, 
these explanations are not entirely satisfactory, sug-
gesting that more needs to be learned about the natural 
history of mtDNA mutations.
Mitochondrial Dynamics and mtDNA Mutations
The symptoms of mtDNA diseases often progressively 
worsen with age. This has usually been explained by 
the unique characteristics of mitochondrial inheritance 
(Dimauro and Davidzon, 2005; DiMauro and Schon, 
2003; Wallace, 2005). Mammalian cells can have hun-
dreds to thousands of mitochondria, and each mito-
chondrion contains several mtDNA genomes. Many 
mtDNA diseases, such as MERRF and MELAS, exist 
in a heteroplasmic state. Because of the stochastic 
nature of mitochondrial inheritance during cell division, 
a daughter cell can occasionally inherit a population of 
mitochondria whose ratio of mutant to wild-type mtDNA 
differs significantly from that of the parental cell (Figure 
2, left panel). Cells with high levels of mutant mtDNA will 
have lower respiratory capacity, and eventually a bioen-
ergetic threshold is breached that results in mitochon-
drial dysfunction. Depending on the natural history of 
such stochastic events, entire tissues can be severely 
affected if skewing of mtDNA inheritance occurs early in 
the development of the tissue. In extreme cases of this 
genetic drift, a particular cell can become homoplasmic 
for the mutant mtDNA. Such a state is irreversible for the 
cell, and all its progeny will remain homoplasmic. In fact, 
some mtDNA diseases, such as LHON (Leber’s heredi-
tary optic neuropathy), are often homoplasmic.
This simplistic view of mtDNA inheritance—where 
mitochondria are distinct particles passively await-
ing segregation by the cytokinesis machinery—ignores 
the potential role of mitochondrial dynamics, a promi-
nent feature of these organelles (Figure 2, right panel). 
Any given mitochondrion is not a discrete, autonomous 
organelle. In fact, the identity of an individual mitochon-
drion is short-lived, because it will fuse with a neighbor-
ing mitochondrion in the near future. Therefore, the entire 
mitochondrial population is in constant flux, driven by 
continual fusion and division of mitochondria (Figure 1). 
If two or more cultured mammalian cells are artificially 
fused to form a cell hybrid, the mitochondrial popula-
tions are completely fused within 8 hr (Chen et al., 2003; 
Legros et al., 2002; Mattenberger et al., 2003). For rea-
sons that are not clear, functional complementation of 
mtDNA gene products does not appear to happen until 
several days later (Ono et al., 2001).
Mitochondrial fusion results in mixing of not only 
the outer and inner mitochondrial membranes but also 
the contents of the mitochondrial matrix. The effects 
of these processes on the natural history of mtDNA 
mutations have yet to be studied, and important issues 
remain to be resolved. For example, mtDNA is organized 
into discrete units termed nucleoids that contain several 
mtDNA genomes. A given mitochondrion can contain 
multiple nucleoids, and mitochondrial fusion results in 
cohabitation of nucleoids within the same mitochon-
drion. It is not clear to what extent fusion of mitochondria 
results in mixing of mtDNA nucleoids and, as a corol-
lary, the mixing of mtDNA genomes. mtDNA nucleoids 
are highly dynamic (Garrido et al., 2003; Iborra et al., 
2004; Legros et al., 2004) and have been observed to 
merge and divide (Garrido et al., 2003). Given the evi-
dence of human mitochondrial DNA recombination after 
fusion (D’Aurelio et al., 2004; Kraytsberg et al., 2004), 
some mixing of mtDNA nucleoids must occur. However, 
mtDNA recombination in human cells seems to occur 
at only modest levels (D’Aurelio et al., 2004; Kraytsberg 
et al., 2004), and though mtDNA nucleoids are cer-
tainly mobile after mitochondrial fusion, their movement 
is somewhat restricted compared to matrix proteins 
(Legros et al., 2004).
Although these important issues await clarification, 
several potential consequences of mitochondrial dynam-ics on mtDNA mutations should be considered. First, 
because cells continually fuse and divide mitochondria, 
any given mitochondrion within a heteroplasmic cell will 
likely contain both mutant and wild-type mtDNA. Indi-
vidual mitochondria within a heteroplasmic cell cannot 
be considered as containing either solely mutant or 
solely wild-type mtDNA (Figure 2, right panel). There-
fore, before the segregation of the mitochondrial popu-
lation by cytokinesis, the individual mitochondria have 
already been “pre-homogenized.” A consequence of this 
premixing is that fluctuations in mutant/wild-type mtDNA 
ratios in the daughter cells are dampened, and the likeli-
hood of producing homoplasmic cells is reduced. Given 
that homoplasmy does occur in some mtDNA diseases, 
mitochondrial fusion and fission are clearly not a fool-
proof mechanism to ensure heteroplasmy, but the extent 
of their protective effect should be assessed. Indeed, 
it is possible that certain tissues have lower levels of 
these processes and are more prone to drifts in levels of 
mutant mtDNA. Second, as mentioned above, it is possi-
ble that mitochondrial fusion results in mixing of mutant 
and wild-type mtDNA within nucleoids. This will be an 
important issue to resolve because mixing of mutant and 
wild-type mtDNA within nucleoids would further help 
to reduce large fluctuations in mutant mtDNA levels in 
daughter cells. Finally, regardless of whether nucleoids 
mix, mitochondrial fusion allows mutant and wild-type 
mtDNA gene products to mix within mitochondria. Such 
mixing allows maintenance of full mitochondrial function 
in cells containing significant levels of mtDNA mutations 
(Nakada et al., 2001).
Figure 2. Mitochondrial Dynamics May Dampen Fluctuations 
in mtDNA Inheritance
(Left panel) Traditional view of mtDNA inheritance. Mitochondria are 
considered as discrete particles that contain either wild-type (gray) or 
mutant (red) mtDNA. Segregation is random and can occasionally give 
rise to a daughter cell with high mutational load. After many divisions 
(indicated by dashed line), such genetic drift can eventually result in a 
homoplasmic cell (bottom).
(Right panel) View incorporating mitochondrial dynamics. Because of 
mitochondrial fusion, mitochondria (purple) in heteroplasmic cells are 
highly intermixed and contain both wild-type and mutant mtDNA. As 
a result, genetic drift in daughter cells is minimized. For simplicity, the 
organization of mtDNA into nucleoids is not depicted.Cell 125, June 30, 2006 ©2006 Elsevier Inc. 1243
Mitochondrial Fusion and Fission
Mitochondrial fusion involves the coordinated fusion 
of both the outer and inner mitochondrial membranes. 
Genetic studies in yeast have been instrumental in iden-
tifying the molecular players in mitochondrial dynamics 
(Bleazard et al., 1999; Hermann et al., 1998; Mozdy et 
al., 2000; Okamoto and Shaw, 2005; Sesaki and Jensen, 
1999; Tieu et al., 2002), and orthologs of many of these 
genes play similar functions in mammalian cells. Mito-
fusins are GTPases localized to the outer mitochondrial 
membrane. Mammals have two mitofusin genes, Mfn1 
and Mfn2 (Chen et al., 2003). These are the only mam-
malian outer membrane proteins known to be essential 
for mitochondrial fusion, and therefore are prime candi-
dates for directly mediating the fusion process (Koshiba 
et al., 2004). In addition to Mfn1 and Mfn2, the dynamin 
family GTPase OPA1 is essential for mitochondrial fusion 
(Chen et al., 2005; Cipolat et al., 2004). This mitochon-
drial intermembrane space protein is associated with the 
inner membrane and may also play a role in control of 
inner membrane structure (Griparic et al., 2004). Both 
Mfn2 and OPA1 are associated with neurodegenerative 
diseases (Alexander et al., 2000; Delettre et al., 2000; 
Zuchner et al., 2004).
The opposing process of mitochondrial fission 
depends on the dynamin-related protein Drp1 (Smirnova 
et al., 2001). This GTPase localizes to discrete spots on 
mitochondria, and a subset of such spots mark sites of 
future fission. The classical dynamin protein is capable of 
assembling onto lipid membranes, resulting in their con-
striction, tubulation, or vesiculation depending on exper-
imental conditions. Given these properties, dynamins 
have been proposed to be mechanochemical enzymes 
that use GTP hydrolysis to drive membrane scission 
(Praefcke and McMahon, 2004). Like dynamin, the yeast 
Drp1 ortholog, Dnm1, also assembles into multimeric 
complexes that constricts lipid membranes (Ingerman 
et al., 2005). Therefore, it is likely that Drp1 plays a role 
in membrane constriction during the process of mito-
chondrial fission. Much of Drp1 exists in the cytosol, and 
how a subpopulation is recruited to discrete spots on 
mitochondria remains unclear. The mechanisms recruit-
ing fission complexes to mitochondria are best under-
stood in yeast, where Dnm1 localization to mitochondria 
clearly relies on the outer mitochondrial protein Fis1 and 
two adaptor proteins (Griffin et al., 2005; Mozdy et al., 
2000; Okamoto and Shaw, 2005; Tieu et al., 2002). Sur-
prisingly, knockdown of Fis1 in mammalian cells by RNA 
interference does not disrupt the mitochondrial localiza-
tion of Drp1 (Lee et al., 2004).
Mitochondrial Fusion and Division during 
 Development
As might be expected for such a fundamental cellular 
process, mitochondrial fusion is essential for embryonic 
development (Chen et al., 2003). Loss of either Mfn1 or 
Mfn2 results in a large reduction in mitochondrial fusion 
and in midgestational lethality. In the case of Mfn2 null 1244 Cell 125, June 30, 2006 ©2006 Elsevier Inc.mice, this lethality is due to improper development of 
the placenta (Chen et al., 2003). The midgestational 
placenta has a trilaminar structure, in which trophoblast 
giant cells form the outermost layer that is juxtaposed 
against the maternal decidua. Trophoblast giant cells 
are special polyploid cells that undergo DNA replication 
but not cytokinesis. Polyploidy is often associated with 
a commensurate increase in the cytoplasmic compart-
ment, and in this case, the trophoblast cells grow into 
enormous cells that play important roles in invasion of 
the placenta into the uterine lining, secretion of hormones 
that support pregnancy, and promotion of maternal-fetal 
blood exchange. In Mfn2 mutant mice, the trophoblast 
giant cell layer is sparse and incomplete, resulting in pla-
cental insufficiency that fails to maintain viability of the 
embryo. Trophoblast cells from Mfn2 mutant mice show 
fragmentation of the mitochondrial population. Like-
wise, mouse embryonic fibroblasts lacking either Mfn1 
or Mfn2 also show severe fragmentation of mitochon-
dria. This fragmentation is due to ongoing fission in the 
face of drastically reduced fusion. Mitochondrial tubules 
can be restored to such mutant cells by concomitantly 
blocking the fission pathway with a dominant-negative 
version of Drp1.
Based on these results and related experiments in 
yeast (Bleazard et al., 1999; Okamoto and Shaw, 2005; 
Sesaki and Jensen, 1999), it is clear that mitochondrial 
morphology is a highly dynamic parameter that can be 
regulated by adjusting the balance between the oppos-
ing processes of fusion and fission. Reducing the rela-
tive rate of fusion results in mitochondrial fragmentation 
due to unopposed fission (Chen et al., 2003; Hermann 
et al., 1998); conversely, reducing the relative rate of 
fission results in excessive elongation and intercon-
nectivity of the mitochondrial network (Bleazard et al., 
1999; Labrousse et al., 1999; Sesaki and Jensen, 1999; 
Smirnova et al., 2001). Such changes in the balance of 
fusion and fission may underlie the range of mitochon-
drial morphologies—from small spheres to tubular net-
works—observed in various cell types.
Mitochondria of a particular morphological class may 
have functional advantages depending on the cellular 
environment. For example, it has been proposed that 
highly elongated mitochondria may enable the rapid 
transmission of membrane potential across significant 
distances within a cell (Skulachev, 2001). In some cases, 
highly active mitochondria are associated with elonga-
tion of tubules, such as in yeast forced to respire by 
growth in glycerol, a nonfermentable carbon source. In 
other cases, fragmentation of the mitochondrial network 
may facilitate recruitment of mitochondria to cellular 
compartments in need of ATP. For example, fragmenta-
tion of mitochondria in hippocampal neurons appears to 
facilitate recruitment of mitochondria into neuronal pro-
trusions, which tend to retract unless mitochondria are 
recruited to their vicinity (Li et al., 2004).
But are mitochondrial fusion and fission required only 
for control of mitochondrial morphology and distribu-
tion? If that were the case, loss of fusion would result 
in mitochondrial fragmentation, but the small mito-
chondrial spheres would otherwise be able to carry out 
normal mitochondrial functions. Recent results argue 
against this scenario. Cells lacking all mitochondrial 
fusion—due to deletion of both Mfn1 and Mfn2 or loss of 
OPA1—show severe cellular defects (Chen et al., 2005). 
Such cells grow very slowly and have reduced activity 
for all respiratory complexes. The respiratory deficiency 
is associated with extensive interorganellar heterogene-
ity, such that many of the mitochondria in mutant cells 
have reduced membrane potential. Thus mitochondrial 
fusion appears to be important not only for control of 
mitochondrial shape but also for maintenance of mito-
chondrial function. The functional deficits suggest that 
mitochondria need to cooperate with each other through 
fusion (Chen et al., 2003, 2005).
Mitochondrial fission also appears to play important 
roles in mitochondrial function. RNA interference against 
Drp1 in Caenorhabditis elegans leads to early embryonic 
lethality, before embryos reach 100 cells (Labrousse et 
al., 1999). Disruption of Drp1 causes loss of proper mito-
chondrial localization and probably improper segrega-
tion of mitochondria in dividing cells. Moreover, mito-
chondrial fission is necessary for proper recruitment of 
mitochondria to nerve terminals (Verstreken et al., 2005), 
a topic discussed in detail below.
Finally, recent studies indicate that mitochondrial 
fission is involved in the induction of programmed cell 
death, an important area that has been reviewed exten-
sively (Perfettini et al., 2005; Youle and Karbowski, 2005). 
During apoptosis, Bcl2 family members Bax and Bak 
coalesce on the mitochondrial surface and cause outer 
membrane permeabilization, which allows cytochrome c 
sequestered in the mitochondrial intermembrane space 
to be released into the cytosol. Cytochrome c release is 
a key event leading to activation of caspases, cysteine 
proteases necessary for cell death. In many cases of 
cells undergoing apoptosis, mitochondrial fragmentation 
is an early event that precedes caspase activation (Frank 
et al., 2001). This fragmentation occurs close in time to 
two other important events: the coalescence of Bax 
and Bak on the mitochondrial surface and cytochrome 
c release (Youle and Karbowski, 2005). Mitochondrial 
fragmentation during apoptosis is dependent on the 
normal mitochondrial fission machinery, and inhibition 
of Drp1 or Fis1 prevents mitochondrial fragmentation, 
inhibits cytochrome c release, and can delay or reduce 
the extent of cell death (Breckenridge et al., 2003; Frank 
et al., 2001; Lee et al., 2004). In C. elegans, specific 
cells destined to undergo developmentally regulated 
cell death show mitochondrial fragmentation, and like-
wise, prevention of such fragmentation leads to the sur-
vival of some of these cells (Jagasia et al., 2005). These 
results suggest an intriguing link between mitochondrial 
fission and permeabilization of the mitochondrial outer 
membrane, but the molecular mechanism remains to be 
explored. In contrast, mitochondrial fusion may play a protective role in apoptosis. Inhibition of mitochondrial 
fusion facilitates cell death in response to some apop-
totic signals (Olichon et al., 2003; Sugioka et al., 2004).
Mitochondrial Dynamics and Neurodegeneration
Mutations in Mfn2 cause Charcot-Marie-Tooth (CMT) 
subtype 2A (Zuchner et al., 2004). CMT is a group of dis-
eases characterized by pathology in the longest motor 
and sensory nerves, which enervate the hands and feet 
(Zuchner and Vance, 2005). The most common forms 
of CMT result from defects in Schwann cell function, 
resulting in demyelination of peripheral nerves. CMT2A 
is an axonal form, thought to be caused by defects in the 
neurons themselves.
CMT2A has an autosomal-dominant pattern of 
inheritance and has been associated with over 20 
mutations in Mfn2 (Zuchner et al., 2004; Zuchner and 
Vance, 2005). Most of the mutations lie within or near 
the GTPase domain, although a few occur in the car-
boxy-terminal region. Because these alleles remained 
to be characterized functionally, it is unknown how 
they affect mitochondrial dynamics and consequently 
neuronal function. Because of the dominant inherit-
ance pattern and the known requirement of the GTPase 
domain in mitofusin function, it has been suggested 
that CMT2A is due to haploinsufficiency of Mfn2 (Zuch-
ner et al., 2004). However, mice heterozygous for an 
Mfn2 null mutation show no functional deficits (Chen et 
al., 2003). Another possibility is that CMT2A mutations 
are dominantly acting alleles of Mfn2 that affect the 
wild-type Mfn2 still expressed from the normal allele. 
In addition, because Mfn2 can associate with itself and 
with Mfn1 (Chen et al., 2003), it is possible that CMT2A 
alleles of Mfn2 also affect Mfn1 function. Resulting 
changes in the morphology, movement, or distribution 
of mitochondria may hinder the recruitment of these 
organelles to the nerve terminal.
Due to the extraordinary length of motor and sensory 
neurons that enervate the distal limbs, it is plausible 
that quite subtle perturbations in mitochondrial dynam-
ics can, over time, lead to severe physiological defects. 
Timelapse imaging of mitochondrial transport in neu-
rons indicates a transport rate of 0.1 to 1 µm per sec-
ond (Morris and Hollenbeck, 1995). Furthermore, such 
movements are saltatory and therefore net rates over 
long distances are probably significantly slower. Even 
with the generous assumption of 1 µm/s, it would take a 
mitochondrion located within a motor neuron cell body 
about 2 weeks to travel to the nerve periphery located 
in the distal limbs. Therefore, small changes in mito-
chondrial dynamics could have severe consequences 
for neurons, and to address these issues, investigations 
of mitochondrial dynamics may have to shift from more 
familiar cell types such as fibroblasts to culture systems 
that better represent the unique cell biological features 
of neurons.
Mfn2 is not the only mitochondrial morphology gene 
involved in Charcot-Marie-Tooth disease. Ganglioside-Cell 125, June 30, 2006 ©2006 Elsevier Inc. 1245
induced differentiation associated protein 1 (GDAP1), 
a mitochondrial outer membrane protein with tandem 
glutathione transferase domains, is mutated in CMT4A 
(Zuchner and Vance, 2005). CMT4A is a recessive dis-
ease with clinical heterogeneity; patients can have 
features of myelin or axonal defects, or a combina-
tion of both. This mixed clinical presentation may be 
due to the fact that both neurons and Schwann cells 
express GDAP1. GDAP1 has been proposed to func-
tion in mitochondrial fission, based on the observation 
that overexpression leads to mitochondrial fragmenta-
tion (Niemann et al., 2005). In addition, knockdown of 
GDAP1 leads to increased tubulation of the mitochon-
drial population. Currently, it is unknown how GDAP1 
affects the mitochondrial fusion or fission machin-
ery, although mitochondrial fragmentation caused 
by GDAP1 overexpression can be alleviated by Mfn1 
or Mfn2 overexpression and depends on Drp1 func-
tion. Mutants of GDAP1 associated with CMT4A have 
either loss of mitochondrial targeting or reduced mito-
chondrial fragmentation activity. These results further 
emphasize the sensitivity of long peripheral nerves to 
perturbations in mitochondrial dynamics.
Autosomal dominant optic atrophy (DOA), also 
termed Kjer’s disease, results in loss of visual acuity 
and is caused by degeneration of retinal ganglion cells 
(Delettre et al., 2002). The major form of DOA is caused 
by mutations in OPA1, a mitochondrial intermembrane 
space protein that is essential for mitochondrial fusion. 
Almost 100 OPA1 mutations (http://lbbma.univ-angers.fr/ 
eOPA1/) have been identified, and a few of these result 
in extreme truncation of OPA1. In such cases, the phe-
notypic effects are likely due to haploinsufficiency. How-
ever, many mutations occur in the GTPase domain or the 
central region of OPA1, and about half the mutations are 
truncations. Given the tendency of dynamin family mem-
bers to form oligomers, it is quite possible that many of 
the OPA1 mutations are dominant-negative alleles that 
reduce the activity of the remaining wild-type allele, lead-
ing to the autosomal-dominant pattern of inheritance. In 
addition, it is also possible that some of these alleles 
have dominant gain-of-function activities, although this 
has yet to be experimentally demonstrated.
It remains unclear how OPA1 mutations lead to 
degeneration of retinal ganglion cells. Monocytes 
from patients show clumped mitochondria (Delettre et 
al., 2000). OPA1 is expressed throughout the retina, 
and knockdown of OPA1 results in the formation of 
mitochondrial aggregates (Kamei et al., 2005). Clinical 
analysis of some patients have indicated reduced cop-
ies of mtDNA and reduced oxidative phosphorylation 
in skeletal muscle (Kim et al., 2005; Lodi et al., 2004). 
Such defects may be related to the severe reduction 
of mitochondrial membrane potential and respiration 
that occur in OPA1-deficient cells (Chen et al., 2005). 
Loss of OPA1 also leads to apoptosis (Olichon et al., 
2003) and severe defects of cristae within mitochon-
dria (Griparic et al., 2004).1246 Cell 125, June 30, 2006 ©2006 Elsevier Inc.There are hints that diseases caused by Mfn2 and 
OPA1 mutations may have additional parallels to phe-
notypes seen in classic mtDNA diseases. In addition 
to CMT2A, a form of CMT with optic atrophy is also 
caused by Mfn2 mutations, implying that perturbations 
in mitochondrial dynamics may have broader involve-
ment of neurons (Zuchner et al., 2006). With DOA, 
some families have associated neurosensory hearing 
loss, and one family has been reported to have ptosis 
and opthalmoplegia (Payne et al., 2004). It remains to 
be determined whether the latter defects result from 
skeletal muscle dysfunction, a common feature of many 
mtDNA diseases. Finally, LHON, one of the most com-
mon mtDNA diseases, results in optic nerve atrophy and 
has clinical features similar to DOA (Carelli et al., 2004). 
These parallels suggest that perturbations in mitochon-
drial dynamics can affect some of the same tissues as 
mtDNA diseases. In yeast, loss of mitochondrial fusion 
results in subsequent loss of mtDNA (Hermann et al., 
1998). In mammalian cells, loss of mitochondrial fusion 
does not result in complete loss of mtDNA (Chen et al., 
2003, 2005), but it remains to be determined whether 
more subtle mtDNA defects are present. Studies on the 
mechanism of the disease alleles in CMT2A and DOA 
will be necessary to evaluate whether changes in mtDNA 
play a role in disease pathogenesis.
Transport of Mitochondria to the Nerve Terminal
The diseases discussed indicate that neurons are par-
ticularly vulnerable to mitochondrial dysfunction. Do 
mitochondria have unique roles in neurons? Indeed, 
the synaptic regions of axons are well known to contain 
abundant mitochondria, ever since their initial ultrastruc-
tural characterization by electron microscopy in the early 
days of cell biology. This highly localized abundance of 
mitochondria probably reflects the intense ATP demands 
of an active neuron engaged in synaptic transmission, 
including ATP-dependent fusion and recycling of synaptic 
vesicles and ATP-driven pumps to control the ionic envi-
ronment at the synaptic membrane. In addition, uptake of 
calcium by mitochondria may be important in buffering 
calcium levels. A series of studies in Drosophila has pro-
vided genetic evidence for the functional importance of 
these synaptic mitochondria. Disruption of Milton, Drp1, 
or Miro leads to a severe loss of mitochondria in the ter-
minals of specific classes of neurons (Guo et al., 2005; 
Stowers et al., 2002; Verstreken et al., 2005). Milton is a 
large coiled-coil-containing protein that localizes to mito-
chondria (Stowers et al., 2002). It binds to kinesin heavy 
chain and has been proposed to mediate the transport of 
mitochondria to the nerve terminal along the microtubule 
cytoskeleton. Loss of Milton in photoreceptor cells results 
in complete loss of mitochondria from the photoreceptor 
cell terminals and loss of synaptic transmission, but the 
structure of the synapse is largely intact.
Miro (mitochondrial Rho-GTPase) is a mitochondrial 
outer membrane proteins with two GTPase domains and 
two Ca2+ binding EF hand motifs (Fransson et al., 2003). 
Overexpression of an activated Miro in cultured cells 
causes mitochondria to aggregate perinuclearly and 
sensitizes cells to apoptosis. The yeast Miro ortholog, 
Gem1, has been shown to be essential for normal mito-
chondrial morphology, although it does not appear to be 
directly involved in either mitochondrial fusion or fission 
(Frederick et al., 2004). Loss of Miro in flies results in 
accumulation of mitochondria within the neuronal cell 
bodies, absence of mitochondria from the neuromuscu-
lar junction, and impaired larval movement (Guo et al., 
2005). Interestingly, mutant flies have structural altera-
tions in the neuromuscular junction. There is an increase 
in the number of synaptic boutons (swellings at the 
nerve terminal that form synapses), and such boutons 
are smaller and tend to cluster more closely together. 
Neuromuscular junctions lacking Drp1 similarly lack 
mitochondria but did not appear to have such structural 
Figure 3. Unique Challenges for Mitochondria in Neurons
Shown on the left is a neuron, with mitochondria (brown ovals). Note 
that only a relatively short neuron is depicted; the axons of some neu-
rons are much longer. Mitochondria travel long distances from the cell 
body to dendritic (top right) and axonal processes (bottom right). In 
the dendritic arbor, mitochondrial recruitment to protrusions (spines) 
is associated with neuronal activation. In boutons at the nerve termi-
nal, mitochondria are important for calcium buffering and cycling of 
reserve pool synaptic vesicles (the subset of green vesicles highlight-
ed by dashed oval). In addition, they are necessary for proper bouton 
structure and organization.defects (Verstreken et al., 2005). In both cases, resting 
Ca2+ levels at the nerve terminal were elevated, but Ca2+ 
buffering following nerve stimulation is not significantly 
impaired unless the stimulation is maintained at high 
intensity for extended time periods. Filling Drp1 mutant 
neurons with ATP partially rescues their ability to main-
tain neurotransmission during high-frequency stimula-
tion. Exocytosis of synaptic vesicles and their recycling 
by endocytosis, both ATP-dependent processes, appear 
to be unaltered. However, a subpopulation of synaptic 
vesicles, the reserve pool, appears to be dysfunctional in 
Drp1 mutant animals. Taken together, these studies indi-
cate a role for mitochondria in regulating calcium levels 
at the nerve terminal, but these effects appear modest 
and only become significant with sustained high-level 
nerve activity. The main requirement for mitochondria 
appears to be in providing ATP (Figure 3).
Just as mitochondria need to be recruited into axonal 
processes, they are also recruited into dendritic spines. 
There is a correlation between dendritic spine morpho-
genesis and recruitment of nearby mitochondria (Li et 
al., 2004). Activation of hippocampal neurons leads to 
increased recruitment of mitochondria into dendritic 
spines. Molecules involved in mitochondrial dynamics, 
including OPA1 and Drp1, affect this recruitment.
mtDNA Mutations and Aging
Although the role of mitochondrial fission and fusion pro-
teins has not been examined in the association between 
mtDNA mutations and aging or metabolic disorders, 
it is tempting to speculate that these proteins may be 
involved given their importance in development and cer-
tain diseases. In this section and the next, we describe 
studies linking mitochondrial dysfunction to aging and 
metabolic disorders.
The mitochondrial respiratory chain is exquisitely 
tuned to transfer electrons from NADH or FADH to a 
series of electron acceptors, until the final transfer to 
oxygen leads to production of water. However, these 
biochemical reactions have an inherent danger because 
electron leakage can lead to the production of reactive 
oxygen species (ROS). A low level of ROS production is 
an unavoidable byproduct of respiratory chain function, 
and therefore mitochondria are a major source of ROS 
in a eukaryotic cell. Because mtDNA is spatially close to 
the source of ROS production, it is thought to be par-
ticularly vulnerable to ROS-mediated mutations. Levels 
of oxidized guanosine are much higher in mtDNA than 
in nuclear DNA (Richter et al., 1988). Several DNA repair 
mechanisms operate within mitochondria, but nucle-
otide excision repair is notably absent and likely leaves 
mtDNA vulnerable to a number of DNA lesions inflicted 
by exogenous mutagens (Larsen et al., 2005). In addi-
tion to impairment of respiration, mutations in mtDNA 
can have a second, more insidious consequence. Mito-
chondrial DNA mutations that reduce the accuracy of 
electron transfer increase the likelihood of ROS produc-
tion and further mtDNA lesions, leading to a so-called Cell 125, June 30, 2006 ©2006 Elsevier Inc. 1247
“vicious cycle.” This scenario is the basis for the hypoth-
esis that mitochondrial dysfunction plays a critical role in 
the aging process (Harman, 1956, 1972; Linnane et al., 
1989). In this view, aging is caused by the ROS-acceler-
ated accumulation of mtDNA damage, leading to a pro-
gressive decline in respiratory function over time.
In support of this hypothesis, many tissues from aged 
individuals have lower respiratory function compared 
to those from younger individuals (Boffoli et al., 1994; 
Cooper et al., 1992; Trounce et al., 1989). Both mtDNA 
point mutations and deletions are indeed more prevalent 
in aged tissues and cells. Numerous studies have doc-
umented the presence of large mtDNA deletions from 
muscle and brain from old individuals, at levels ranging 
from 1%–10%. Muscles from old individuals also have 
a higher incidence of fibers defective for cytochrome c 
oxidase, a mitochondrial enzyme with subunits encoded 
by mtDNA. Thus it appears that occasional cells from 
old individuals can have high levels of mtDNA contain-
ing deletions, leading to heterogeneity in respiratory 
function between individual cells (Chomyn and Attardi, 
2003). Strikingly, aging is associated with clonal mtDNA 
deletions and respiratory incompetence in single neu-
rons in the substantia nigra. Such defects accumulate 
during normal aging and may be involved in loss of 
substantia nigra cells in Parkinson’s disease (Bender et 
al., 2006; Kraytsberg et al., 2006). Furthermore, there 
is evidence that hallmarks of ROS-mediated nucleotide 
damage, such as 8-hydroxy-2-deoxyguanosine, are 
more prevalent in aged tissues. Finally, point mutations 
in mtDNA also appear at a higher frequency in tissues 
of old individuals. Whereas some point mutations are 
found at very low levels, others accumulate to very high 
abundance, from 20%–50% of the total mtDNA (Michi-
kawa et al., 1999).
Although these studies show that aging is associ-
ated with declining respiratory function, accumulation 
of variable levels of mtDNA deletions and point muta-
tions, and accumulation of oxidative damage to mtDNA, 
there remain substantial concerns about whether these 
changes are causal in the aging process. First, some 
studies suggest that the respiratory decline in old 
individuals is largely due to physical inactivity, rather 
than chronological age (Brierley et al., 1997). Second, 
the functional significance of the mtDNA alterations is 
unclear. The levels of mtDNA mutations (a few percent) 
found in most studies are too low to affect respiratory 
function. In cell culture and animal model systems, no 
defect in respiration is found until pathogenic mtDNA 
genomes reach very high levels (Hayashi et al., 1991; 
Nakada et al., 2001; Yoneda et al., 1994). It should be 
noted, though, that the low levels of mtDNA mutations 
found in bulk tissue samples may sometimes reflect 
cellular heterogeneity within the tissue; individual cells 
within the tissue can carry high loads that lead to mito-
chondrial dysfunction. Finally, although specific point 
mutations in mtDNA mutations can reach high levels in 
aged individuals (Michikawa et al., 1999), the effect of 1248 Cell 125, June 30, 2006 ©2006 Elsevier Inc.these mutations on mitochondrial function remains to be 
determined.
Recent mouse models have further implicated mtDNA 
mutations in the aging process. Two groups have con-
structed mice containing a point mutation in the proof-
reading domain of DNA polymerase-γ (POLG), the cata-
lytic subunit of mtDNA polymerase (Kujoth et al., 2005; 
Trifunovic et al., 2004). The mutant DNA polymerase-γ 
has normal DNA polymerase activity but lacks the exo-
nuclease activity necessary for proofreading. Mice carry-
ing homozygous mutations show a substantial increase 
(3- to 8-fold) in mtDNA point mutations in several tis-
sues. Remarkably, such “mutator” mice have reduced 
life spans and additional features that could be inter-
preted as accelerated aging. They show an early onset 
of a number of age-associated features, including weight 
loss, reduction in subcutaneous fat, hair loss, curvature 
of the spine, and osteoporosis. It should be noted, how-
ever, that not all mice harboring increased mtDNA muta-
tions have such an aging phenotype (Tyynismaa et al., 
2005).
At first glance, these remarkable phenotypes would 
seem to support the hypothesis for the mitochondrial 
basis of aging. However, one of the key features of this 
hypothesis is that mtDNA mutations lead to increased 
ROS production, which leads to further mtDNA damage 
and cellular damage. Remarkably, in spite of the wide-
spread mtDNA mutations, these mice do not appear 
to have any change in the levels of hydrogen peroxide. 
Furthermore, there is no evidence for increased oxida-
tive damage to proteins, lipids, or DNA (Kujoth et al., 
2005). In contrast, mice overexpressing mitochondri-
ally targeted catalase, an antioxidant, have extended life 
spans, so the debate on the role of ROS will likely con-
tinue (Schriner et al., 2005).
One group found that many tissues in error-prone 
POLG mice contain increased levels of caspase-3, a 
downstream protease activated during many apoptotic 
pathways (Kujoth et al., 2005). This increase in caspase-
3 activation is also observed in tissues from normally 
aged mice. Furthermore, the mutant mice also show 
increased TUNEL staining, an indication of the DNA frag-
mentation that is a hallmark of apoptosis. It is suggested 
that the diverse signs of aging in these mice may be due 
to widespread induction of apoptosis, a phenomenon 
that could rapidly deplete dividing tissues of critical stem 
cells (Kujoth et al., 2005). This induction of apoptosis 
may be related to the observation that patients carrying 
very high loads of certain mtDNA mutations show a high 
degree of TUNEL-positive muscle fibers (Mirabella et al., 
2000). Widespread apoptosis is also found in mouse 
embryos lacking mitochondrial transcription factor A 
(Tfam), which is necessary for mtDNA expression and 
maintenance (Larsson et al., 1998). However, increased 
apoptosis is not a universal feature of mitochondrial 
myopathies (Chomyn and Attardi, 2003).
Certainly, these results provide strong evidence that 
accumulation of mtDNA mutations can induce the pre-
mature emergence of features often associated with the 
aging process. However, the life span of animals is lim-
ited by multiple factors (Kirkwood, 2005), and the gross 
exaggeration of a single factor can, in principle, shorten 
life span. If error-prone POLG mice indeed have accel-
erated aging, it is nevertheless a pathological form of 
aging. Therefore, more work will be needed to deter-
mine to what extent mtDNA mutations play a role in the 
normal aging process, compared to other factors. To 
address this issue, it will be interesting to test if animals 
engineered with a higher fidelity mtDNA polymerase 
have an increase in life span. In addition, it remains to be 
determined whether the widespread apoptosis identified 
in these animals as the cellular basis for the aging phe-
notypes is indeed relevant to normal aging.
Apart from their aging phenotype, these mice hold 
great promise in the construction of mouse models of 
mtDNA disease. Homozygous mutant females are fer-
tile, and their offspring should carry an increased load 
of mtDNA mutations that will be inherited maternally. 
Female offspring that have mtDNA disease phenotypes 
and associated mtDNA mutations will be founders for 
mouse models of mtDNA disease. This approach has 
the potential to generate multiple lines of mice carrying 
diverse mtDNA mutations. Such models will comple-
ment mtDNA disease models generated by other meth-
ods, such as TFAM-deficient mice (Larsson et al., 1998) 
or mice generated from embryos (Inoue et al., 2000) or 
embryonic stem cells artificially fused with cytoplasmic 
vesicles carrying mutant mtDNAs (Kasahara et al., 2006; 
Sligh et al., 2000).
Mitochondria and Metabolic Disorders
Given the critical role that mitochondria play in the citric 
acid cycle, the electron transport chain, oxidative phos-
phorylation, fatty-acid oxidation, and amino acid catabo-
lism, it is not surprising that mitochondrial diseases often 
have an associated metabolic component. The most 
common metabolic sign is lactic acidosis. In addition, 
some mitochondrial encephalomyopathies have unique 
metabolic perturbations. The clearest example of this 
phenomenon is maternally inherited diabetes and deaf-
ness (MIDD), often referred to as simply mitochondrial 
diabetes (Maassen et al., 2004). This disease is charac-
terized by maternal inheritance, hearing impairment, and 
an age-dependent progression of diabetes due to pan-
creatic β cell dysfunction. The disease is caused by the 
A3243G mtDNA mutation, which lies within the tRNALeu 
gene. Remarkably, the identical mtDNA point mutation 
even in the same family can cause an entirely different 
disease, MELAS.
In MIDD, the primary defect related to diabetes is 
thought to be the inappropriate response of pancreatic β 
cells to glucose stimulation. In normal individuals, mito-
chondrial function is a key component of the glucose 
sensor that drives insulin secretion (Lowell and Shulman, 
2005; Maechler and Wollheim, 2001). In response to high 
blood glucose, pancreatic β cells increase glycolysis and oxidative phosphorylation. The resulting increase in 
ATP concentration leads to calcium signals that trigger 
exocytosis of secretory vesicles containing insulin. The 
mitochondrial defect in MIDD patients therefore impairs 
the pancreatic secretion of insulin. Consistent with this 
hypothesis, carriers of the A3243G mutation appear 
to secrete less insulin in response to a glucose bolus 
(Maassen et al., 2004). Moreover, engineered mice with 
severe depletion of mtDNA in pancreatic β cells develop 
diabetes with high blood glucose and low insulin (Silva 
et al., 2000). With age, such mice show loss of β cells.
In addition to its role in β cell pathology, mitochon-
drial dysfunction may be involved in another key aspect 
of the pathogenesis of diabetes. The hallmark of type 2 
diabetes—the most common type of diabetes—is insu-
lin resistance, a condition of unresponsiveness to the 
glucose-lowering property of insulin. In patients with 
type 2 diabetes, insulin-stimulated glucose transport 
into muscle is severely reduced. Normally, binding of 
insulin to receptors on skeletal muscle and liver leads 
to a signaling cascade that activates glucose trans-
porters, resulting in removal of glucose from the blood-
stream. This signaling cascade is inhibited by fatty-
acid metabolites. It has been proposed that defective 
mitochondrial function in muscle can lead to reduced 
fatty-acid oxidation and inhibition of glucose transport 
(Lowell and Shulman, 2005).
Mitochondrial dysfunction is also the cause of a syn-
drome of metabolic defects that includes hypomag-
nesemia, hypertension, and hypercholesterolemia (Wil-
son et al., 2004). This maternally inherited disease is 
associated with a mitochondrial tRNAIle gene mutation 
(T4291C), which is thought to impair proper positioning 
of the tRNA anti-codon. These patients also show some 
classical signs of mitochondrial disease, such as accu-
mulation of ragged-red fibers in skeletal muscle and 
impaired ATP production. Whether these findings are 
relevant for other metabolic disorders with overlapping 
symptoms remains to been seen.
Prospects
Different cells and tissues have distinct sensitivities 
and responses to mitochondrial dysfunction. These 
differences are probably due to the cell-type spe-
cializations that rely on particular functions of mito-
chondria. Most studies of mitochondrial dysfunction 
have naturally focused on the organelles’ bioenergetic 
and metabolic functions, but mitochondria also con-
trol cytosolic calcium levels, regulate apoptosis, and 
assemble iron-sulfur cluster-containing proteins. The 
ability of mitochondria to effectively carry out such 
functions is likely to be influenced by their dynamic 
behavior. Neurons appear particularly vulnerable to 
mitochondrial dysfunction, and many diseases of 
mitochondria result in neurodegeneration. In part, 
this vulnerability may be due to their extreme physical 
dimensions and the need to actively recruit mitochon-
dria to nerve terminals.Cell 125, June 30, 2006 ©2006 Elsevier Inc. 1249
Several prominent clinical features of mtDNA enceph-
alomyopathies remain mysterious, suggesting that much 
remains to be understood about how mtDNA mutations 
lead to disease. The resolution to some of these issues 
will likely require additional insight into the morphology, 
dynamics, and segregation of these organelles. These 
processes likely influence the natural history of mtDNA 
mutations and therefore disease progression. For exam-
ple, does mitochondrial fusion play a protective role 
in dampening fluctuations in the amounts of mutant 
mtDNA in mitochondrial disease and aging? If so, agents 
that affect mitochondrial dynamics may have promise in 
ameliorating disease progression. With recent animal 
models for mtDNA mutations and mitochondrial fusion, 
these issues can be addressed directly. Insights aris-
ing from such studies will extend beyond mitochondrial 
encephalomyopathies and impact our understanding of 
aging and neurodegeneration.
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